269 related articles for article (PubMed ID: 23172920)
1. RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.
Juranek JK; Geddis MS; Song F; Zhang J; Garcia J; Rosario R; Yan SF; Brannagan TH; Schmidt AM
Diabetes; 2013 Mar; 62(3):931-43. PubMed ID: 23172920
[TBL] [Abstract][Full Text] [Related]
2. Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE.
Juranek JK; Geddis MS; Rosario R; Schmidt AM
Eur J Neurosci; 2013 Oct; 38(8):3159-68. PubMed ID: 23941591
[TBL] [Abstract][Full Text] [Related]
3. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.
Toth C; Rong LL; Yang C; Martinez J; Song F; Ramji N; Brussee V; Liu W; Durand J; Nguyen MD; Schmidt AM; Zochodne DW
Diabetes; 2008 Apr; 57(4):1002-17. PubMed ID: 18039814
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of RAGE suppresses peripheral nerve regeneration.
Rong LL; Trojaborg W; Qu W; Kostov K; Yan SD; Gooch C; Szabolcs M; Hays AP; Schmidt AM
FASEB J; 2004 Dec; 18(15):1812-7. PubMed ID: 15576484
[TBL] [Abstract][Full Text] [Related]
5. Role of advanced glycation end products in diabetic neuropathy.
Sugimoto K; Yasujima M; Yagihashi S
Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845
[TBL] [Abstract][Full Text] [Related]
6. RAGE, diabetes, and the nervous system.
Toth C; Martinez J; Zochodne DW
Curr Mol Med; 2007 Dec; 7(8):766-76. PubMed ID: 18331235
[TBL] [Abstract][Full Text] [Related]
7. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways.
Rong LL; Yan SF; Wendt T; Hans D; Pachydaki S; Bucciarelli LG; Adebayo A; Qu W; Lu Y; Kostov K; Lalla E; Yan SD; Gooch C; Szabolcs M; Trojaborg W; Hays AP; Schmidt AM
FASEB J; 2004 Dec; 18(15):1818-25. PubMed ID: 15576485
[TBL] [Abstract][Full Text] [Related]
8. The receptor for advanced glycation end products and its ligands' expression in OVE26 diabetic sciatic nerve during the development of length-dependent neuropathy.
Zglejc-Waszak K; Schmidt AM; Juranek JK
Neuropathology; 2023 Feb; 43(1):84-94. PubMed ID: 35915909
[TBL] [Abstract][Full Text] [Related]
9. Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.
Tesch G; Sourris KC; Summers SA; McCarthy D; Ward MS; Borg DJ; Gallo LA; Fotheringham AK; Pettit AR; Yap FY; Harcourt BE; Tan AL; Kausman JY; Nikolic-Paterson D; Kitching AR; Forbes JM
Diabetologia; 2014 Sep; 57(9):1977-85. PubMed ID: 24957662
[TBL] [Abstract][Full Text] [Related]
10. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options.
Thornalley PJ
Int Rev Neurobiol; 2002; 50():37-57. PubMed ID: 12198817
[TBL] [Abstract][Full Text] [Related]
11. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.
Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563
[TBL] [Abstract][Full Text] [Related]
12.
López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
[TBL] [Abstract][Full Text] [Related]
13. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
14. CD300f immunoreceptor contributes to peripheral nerve regeneration by the modulation of macrophage inflammatory phenotype.
Peluffo H; Solari-Saquieres P; Negro-Demontel ML; Francos-Quijorna I; Navarro X; López-Vales R; Sayós J; Lago N
J Neuroinflammation; 2015 Aug; 12():145. PubMed ID: 26259611
[TBL] [Abstract][Full Text] [Related]
15. Novel insights into the nervous system affected by prolonged hyperglycemia.
Zglejc-Waszak K; Mukherjee K; Korytko A; Lewczuk B; Pomianowski A; Wojtkiewicz J; Banach M; Załęcki M; Nowicka N; Jarosławska J; Kordas B; Wąsowicz K; Juranek JK
J Mol Med (Berl); 2023 Aug; 101(8):1015-1028. PubMed ID: 37462767
[TBL] [Abstract][Full Text] [Related]
16. Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells.
Serafín A; Molín J; Márquez M; Blasco E; Vidal E; Foradada L; Añor S; Rabanal RM; Fondevila D; Bosch F; Pumarola M
Muscle Nerve; 2010 May; 41(5):630-41. PubMed ID: 19918773
[TBL] [Abstract][Full Text] [Related]
17. RAGE and modulation of ischemic injury in the diabetic myocardium.
Bucciarelli LG; Ananthakrishnan R; Hwang YC; Kaneko M; Song F; Sell DR; Strauch C; Monnier VM; Yan SF; Schmidt AM; Ramasamy R
Diabetes; 2008 Jul; 57(7):1941-51. PubMed ID: 18420491
[TBL] [Abstract][Full Text] [Related]
18. Participation of the receptor for advanced glycation end products in efferocytosis.
Friggeri A; Banerjee S; Biswas S; de Freitas A; Liu G; Bierhaus A; Abraham E
J Immunol; 2011 Jun; 186(11):6191-8. PubMed ID: 21502377
[TBL] [Abstract][Full Text] [Related]
19. IL-4 expressing cells are recruited to nerve after injury and promote regeneration.
Pan D; Schellhardt L; Acevedo-Cintron JA; Hunter D; Snyder-Warwick AK; Mackinnon SE; Wood MD
Exp Neurol; 2022 Jan; 347():113909. PubMed ID: 34717939
[TBL] [Abstract][Full Text] [Related]
20. The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice.
Hansen LM; Gupta D; Joseph G; Weiss D; Taylor WR
Lab Invest; 2017 Jan; 97(1):34-42. PubMed ID: 27869797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
